- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Artec Inc/NV+ Add to Watchlist
ATKJ:US0.0300 USD 0.0295 5,900.00%
As of 20:10:00 ET on 12/17/2013.
Company Profile for Artec Inc/NV (ATKJ)
Artec, Inc. is seeking to manufacture, distribute, and market TUBERCIN in the United States and Canada. The Company's product strenghtens the immune system to eradicate various types of cancer in patients without any side effects.
Key Executives for Artec Inc/NV (ATKJ)
|Ronald ShinnChairman||Gerry G KnightExec VP/Coordinator:Funds|
|George E Williams JrDirector||Cecil ThompsonCoordinator:Bahamas|
|Rodney WatsonCoordinator:South Africa|